Status:
COMPLETED
Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
COVID-19
Eligibility:
All Genders
18-70 years
Brief Summary
The purpose of the study is to describe disability following hospitalization in people of working-age surviving COVID-19.
Detailed Description
In December 2019, the Wuhan Municipal Health Committee in China identified an outbreak with viral pneumonia cases of unknown cause. Coronavirus RNA was identified as the causal agent. The disease caus...
Eligibility Criteria
Inclusion
- Adults of working-age (18 to 70 years),
- Hospitalization during the prespecified inclusion period (from March 2020 to March 2021) (NB : in case of transferred patients, inclusion in the DisCOVID study must be carried out in the first place of admission for COVID),
- Laboratory-confirmed SARS-CoV-2 and/or CT-scan showing typical radiological findings,
- SARS-CoV-2 of any duration,
- Ability to comply with study visits,
- Informed written consent
Exclusion
- Return home in less than 72 hours
- Absence of health insurance,
- Inability to fluently speak and/or read French language,
- People under tutorship or curatorship and protected adults.
Key Trial Info
Start Date :
March 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 2 2024
Estimated Enrollment :
530 Patients enrolled
Trial Details
Trial ID
NCT04724395
Start Date
March 31 2021
End Date
July 2 2024
Last Update
April 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cochin Hospital
Paris, France, 75014